TBPH
$18.92
Theravance Bio Ord
$.53
2.88%
TBPH
Earnings Whisper ®
N/A
1st Quarter March 2021
Consensus:  ($1.05)
Revenue:  $17.27 Mil
Tuesday
May 25
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when TBPH reports earnings?
Beat
Meet
Miss

Where is TBPH's stock price going from here?
Up
Flat
Down
Stock chart of TBPH
Analysts
Summary of analysts' recommendations for TBPH
Score
Grade
Pivots
Resistance
$20.34
$19.73
$19.33

$18.72

Support
$18.32
$17.71
$17.31
Tweet
Growth
Description
Theravance Biopharma, Inc. is a biopharmaceutical company. It is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including bacterial infections, central nervous system (CNS)/pain, respiratory disease, and gastrointestinal (GI) motility dysfunction. Theravance Biopharma, Inc. is based in George Town, Cayman Islands.
Peers
InterCeptVertex PharmaceuticalsBioMarin PharmaceuticalRegeneron PharmaceuticalsZoetisUltragenyx PharmaceuticalBristol-Myers SquibbPfizerMerck & Co.Johnson & Johnson